DC Circ. Urged To Overturn Endo-Impax Opioid Deal Win

By Kelly Lienhard · December 22, 2022, 5:49 PM EST

The Federal Trade Commission urged the D.C. Circuit to overturn a lower court's decision that allowed two pharmaceutical companies to continue an alleged pay-for-delay agreement, arguing that the companies are still...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

FTC v. Endo Pharmaceuticals Inc., et al

Case Number

22-5137

Court

Appellate - DC Circuit

Nature of Suit

1410 Antitrust

Date Filed

May 24, 2022